Education

Pulse oximetry detects heart defects in infants early

ModernMedicine.com

WASHINGTON — Pulse oximetry of newborns may be able to detect congenital heart disease early and should be studied further for adoption as a routine newborn health assessment, according to a Scientific Statement from the American Heart Association (AHA) and the American Academy of Pediatrics (AAP), published online July 6 in both Circulation and Pediatrics.

William T. Mahle, M.D., and colleagues on a special AHA/AAP committee reviewed studies conducted from 1966 to 2008 on the use of pulse oximetry in newborns to detect critical congenital heart disease (CCHD).

Analyzing pooled data, the committee found that oximetry performed after 24 hours of life had an estimated sensitivity for detecting CCHD of 69.6 percent, and a positive predictive value of 47.0 percent; however, sensitivity varied radically between studies, ranging from 0 to 100 percent. False-positive results requiring further evaluation were rare, occurring in only 0.035 percent of cases.

Promoted Products

F02 Non-contact Digital Infrare

SpirOx Spirometer/ SpirOx: plus

SpirOx Spirometer/ SpirOx: P

Sonovet ID

Meditech Equipment Co.,Ltd is part of Meditech Group. Product(s) described may not be licensed or available for sale in all countries. Sonotech, Sonovet, iSonic, FOs2pro, Dolphi, Defi, HeartRec,miniScan,Cardios,SpirOx,iBreath, Meditech and all corresponding design marks are trademarks of Meditech. The symbol indicates the trademark is registered. Patent and Trademark Office and certain other countries. All other names and marks mentioned are the trade names, trademarks or service marks of their respective owners. Please see the Instructions for Use for a complete listing of the indications, contraindications, warnings and precautions.

Legal notice Terms and conditions Cookie policy Privacy Policy Professional organisations Careers

To Top

Pulse oximetry detects heart defects in infants early

Promoted Products

Meditech Brands